| Name | Title | Contact Details |
|---|
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.
LeanTaaS is a software company that uses lean principles and predictive analytics to mathematically match the demand for expensive, constrained healthcare resources – operating rooms, infusion chairs, imaging assets, etc.
H2O Plus is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. H2O Plus is based in Chicago, IL. You can find more information on H2O Plus at www.h2oplus.com
Systagenix Wound Management (US) is a Quincy, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Secure Health Plans of Georgia is a Macon, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.